Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2008

Open Access 01-12-2008 | Original investigation

Metabolic syndrome according to different definitions in a rapidly developing country of the African region

Authors: Clara Kelliny, Julita William, Walter Riesen, Fred Paccaud, Pascal Bovet

Published in: Cardiovascular Diabetology | Issue 1/2008

Login to get access

Abstract

Aims

We examined, in a country of the African region, i) the prevalence of the metabolic syndrome (MetS) according to three definitions (ATP, WHO and IDF); ii) the distribution of the MetS criteria; iii) the level of agreement between these three definitions and iv) we also examined these issues upon exclusion of people with diabetes.

Methods

We conducted an examination survey on a sample representative of the general population aged 25–64 years in the Seychelles (Indian Ocean, African region), attended by 1255 participants (participation rate of 80.3%).

Results

The prevalence of MetS increased markedly with age. According to the ATP, WHO and IDF definitions, the prevalence of MetS was, respectively, 24.0%, 25.0%, 25.1% in men and 32.2%, 24.6%, 35.4% in women. Approximately 80% of participants with diabetes also had MetS and the prevalence of MetS was approximately 7% lower upon exclusion of diabetic individuals. High blood pressure and adiposity were the criteria found most frequently among MetS holders irrespective of the MetS definitions. Among people with MetS based on any of the three definitions, 78% met both ATP and IDF criteria, 67% both WHO and IDF criteria, 54% both WHO and ATP criteria and only 37% met all three definitions.

Conclusion

We identified a high prevalence of MetS in this population in epidemiological transition. The prevalence of MetS decreased by approximately 32% upon exclusion of persons with diabetes. Because of limited agreement between the MetS definitions, the fairly similar proportions of MetS based on any of the three MetS definitions classified, to a substantial extent, different subjects as having MetS.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ford ES: Risks for all-cause mortality, cardiovascular disease and diabetes associated with the metabolic syndrome. A summary of the evidence. Diabetes Care. 2005, 28: 1769-78. 10.2337/diacare.28.7.1769.CrossRefPubMed Ford ES: Risks for all-cause mortality, cardiovascular disease and diabetes associated with the metabolic syndrome. A summary of the evidence. Diabetes Care. 2005, 28: 1769-78. 10.2337/diacare.28.7.1769.CrossRefPubMed
2.
go back to reference Kahn R: Metabolic syndrome-what is the clinical usefulness?. Lancet. 2008, 371 (9628): 1892-93. 10.1016/S0140-6736(08)60731-X.CrossRefPubMed Kahn R: Metabolic syndrome-what is the clinical usefulness?. Lancet. 2008, 371 (9628): 1892-93. 10.1016/S0140-6736(08)60731-X.CrossRefPubMed
3.
go back to reference Reaven GM: The metabolic syndrome: is this diagnosis necessary?. Am J Clin Nutr. 2006, 83 (6): 1237-47.PubMed Reaven GM: The metabolic syndrome: is this diagnosis necessary?. Am J Clin Nutr. 2006, 83 (6): 1237-47.PubMed
4.
go back to reference Harzallah F, Alberti H, Ben Khalifa F: The Metabolic Syndrome in an Arab population: a first look at the new International Diabetes Federation criteria. Diabet Med. 2006, 23: 441-44. 10.1111/j.1464-5491.2006.01866.x.CrossRefPubMed Harzallah F, Alberti H, Ben Khalifa F: The Metabolic Syndrome in an Arab population: a first look at the new International Diabetes Federation criteria. Diabet Med. 2006, 23: 441-44. 10.1111/j.1464-5491.2006.01866.x.CrossRefPubMed
5.
go back to reference Ford ES: Prevalence of the Metabolic Syndrome Defined by the International Diabetes Federation Among Adults in the US. Diabetes Care. 2005, 28: 2745-49. 10.2337/diacare.28.11.2745.CrossRefPubMed Ford ES: Prevalence of the Metabolic Syndrome Defined by the International Diabetes Federation Among Adults in the US. Diabetes Care. 2005, 28: 2745-49. 10.2337/diacare.28.11.2745.CrossRefPubMed
6.
go back to reference Aguilar-Salinas CA, Rojas R, Gómez-Pérez FJ, Valles V, Ríos-Torres JM, Franco A, Olaiz G, Rull JA, Sepúlveda J: High prevalence of metabolic syndrome in Mexico. Arch Med Res. 2004, 35 (1): 76-81. 10.1016/j.arcmed.2003.06.006.CrossRefPubMed Aguilar-Salinas CA, Rojas R, Gómez-Pérez FJ, Valles V, Ríos-Torres JM, Franco A, Olaiz G, Rull JA, Sepúlveda J: High prevalence of metabolic syndrome in Mexico. Arch Med Res. 2004, 35 (1): 76-81. 10.1016/j.arcmed.2003.06.006.CrossRefPubMed
7.
go back to reference Can AS, Bersot TP: Analysis of agreement among definitions of metabolic syndrome in non-diabetic Turkish adults: a methodological study. BMC Public Health. 2007, 19:7 (1): 353-10.1186/1471-2458-7-353.CrossRef Can AS, Bersot TP: Analysis of agreement among definitions of metabolic syndrome in non-diabetic Turkish adults: a methodological study. BMC Public Health. 2007, 19:7 (1): 353-10.1186/1471-2458-7-353.CrossRef
8.
go back to reference Santos A-C, Barros H: Impact of metabolic syndrome definitions on prevalence estimates: a study in a Portuguese community. Diabetes Vasc Dis Res. 2007, 4: 320-78. 10.3132/dvdr.2007.059.CrossRef Santos A-C, Barros H: Impact of metabolic syndrome definitions on prevalence estimates: a study in a Portuguese community. Diabetes Vasc Dis Res. 2007, 4: 320-78. 10.3132/dvdr.2007.059.CrossRef
9.
go back to reference Boronat M, Chirino R, Varillas VF, Saavedra P, Marrero D, Fábregas M, Nóvoa FJ: Prevalence of the metabolic syndrome in the island of Gran Canaria: comparison of three major diagnostic proposals. Diabet Med. 2005, 22 (12): 1751-56. 10.1111/j.1464-5491.2005.01745.x.CrossRefPubMed Boronat M, Chirino R, Varillas VF, Saavedra P, Marrero D, Fábregas M, Nóvoa FJ: Prevalence of the metabolic syndrome in the island of Gran Canaria: comparison of three major diagnostic proposals. Diabet Med. 2005, 22 (12): 1751-56. 10.1111/j.1464-5491.2005.01745.x.CrossRefPubMed
10.
go back to reference Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA: Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health. 2007, 7: 220-10.1186/1471-2458-7-220.PubMedCentralCrossRefPubMed Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA: Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health. 2007, 7: 220-10.1186/1471-2458-7-220.PubMedCentralCrossRefPubMed
11.
go back to reference Assmann G, Guerra R, Fox G, Cullen P, Schulte H, Willett D, Grundy SM: Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations. Am J Cardiol. 2007, 99 (4): 541-48. 10.1016/j.amjcard.2006.08.045.CrossRefPubMed Assmann G, Guerra R, Fox G, Cullen P, Schulte H, Willett D, Grundy SM: Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations. Am J Cardiol. 2007, 99 (4): 541-48. 10.1016/j.amjcard.2006.08.045.CrossRefPubMed
12.
go back to reference Athyros VG, Ganotakis ES, Bathianaki M, Monedas I, Goudevenos IA, Papageorgiou AA: Awareness, treatment and control of the metabolic syndrome and its components: A Multicentre Greek Study. Hellenic J Cardiol. 2005, 46: 380-86.PubMed Athyros VG, Ganotakis ES, Bathianaki M, Monedas I, Goudevenos IA, Papageorgiou AA: Awareness, treatment and control of the metabolic syndrome and its components: A Multicentre Greek Study. Hellenic J Cardiol. 2005, 46: 380-86.PubMed
13.
go back to reference Lee C, Huxley R, Woodward M, Zimmet P, Shaw J, Cho N, Kim H, Viali S, Tominaga M, Vistisen D, Borch-Johnsen K, Colagiuri S: Comparisons of metabolic syndrome definitions in four populations of the Asia-Pacific region. Metab Syndr Relat Disord. 2008, 6: 37-46. 10.1089/met.2007.0024.CrossRefPubMed Lee C, Huxley R, Woodward M, Zimmet P, Shaw J, Cho N, Kim H, Viali S, Tominaga M, Vistisen D, Borch-Johnsen K, Colagiuri S: Comparisons of metabolic syndrome definitions in four populations of the Asia-Pacific region. Metab Syndr Relat Disord. 2008, 6: 37-46. 10.1089/met.2007.0024.CrossRefPubMed
14.
go back to reference Choi KM, Kim SE, Kim YE, Choi DS, Baik SH, Lee J: Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population. Metabolism. 2007, 56: 552-8. 10.1016/j.metabol.2006.12.003.CrossRefPubMed Choi KM, Kim SE, Kim YE, Choi DS, Baik SH, Lee J: Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population. Metabolism. 2007, 56: 552-8. 10.1016/j.metabol.2006.12.003.CrossRefPubMed
15.
go back to reference Deepa M, Farooq S, Datta M, Deepa R, Mohan V: Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: The Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev. 2007, 23 (2): 127-34. 10.1002/dmrr.658.CrossRefPubMed Deepa M, Farooq S, Datta M, Deepa R, Mohan V: Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: The Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev. 2007, 23 (2): 127-34. 10.1002/dmrr.658.CrossRefPubMed
16.
go back to reference Chen H-J, Pan W-H: Probable blind spot in the International Diabetes Federation definition of metabolic syndrome. Obesity. 2007, 15: 1096-1100. 10.1038/oby.2007.633.CrossRefPubMed Chen H-J, Pan W-H: Probable blind spot in the International Diabetes Federation definition of metabolic syndrome. Obesity. 2007, 15: 1096-1100. 10.1038/oby.2007.633.CrossRefPubMed
17.
go back to reference Feng Y, Hong X, Li Z, Zhang W, Jin D, Liu X, Zhang Y, Hu FB, Wei L-J, Zang T, Xu X, Xu X: Prevalence of metabolic syndrome and its relation to body composition in a chinese rural population. Obesity. 2006, 14 (11): 2089-98. 10.1038/oby.2006.244.CrossRefPubMed Feng Y, Hong X, Li Z, Zhang W, Jin D, Liu X, Zhang Y, Hu FB, Wei L-J, Zang T, Xu X, Xu X: Prevalence of metabolic syndrome and its relation to body composition in a chinese rural population. Obesity. 2006, 14 (11): 2089-98. 10.1038/oby.2006.244.CrossRefPubMed
18.
go back to reference Fezeu L, Balkau B, Kengne AP, Sobngwi E, Mbanya JC: Metabolic syndrome in a Sub-Saharan African setting: central obesity may be the key determinant. Atherosclerosis. 2007, 193 (1): 70-76. 10.1016/j.atherosclerosis.2006.08.037.PubMedCentralCrossRefPubMed Fezeu L, Balkau B, Kengne AP, Sobngwi E, Mbanya JC: Metabolic syndrome in a Sub-Saharan African setting: central obesity may be the key determinant. Atherosclerosis. 2007, 193 (1): 70-76. 10.1016/j.atherosclerosis.2006.08.037.PubMedCentralCrossRefPubMed
19.
go back to reference Alberti KG, Zimmet PZ, for the WHO Consultation: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus and its complications. Provisional report of a WHO consultation. Diabet Med. 1998, 15: 539-53. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.CrossRefPubMed Alberti KG, Zimmet PZ, for the WHO Consultation: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus and its complications. Provisional report of a WHO consultation. Diabet Med. 1998, 15: 539-53. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.CrossRefPubMed
20.
go back to reference Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F, American Heart Association; National Heart, Lung and Blood Institute: Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation. 2005, 112 (17): 2735-52. 10.1161/CIRCULATIONAHA.105.169404.CrossRefPubMed Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F, American Heart Association; National Heart, Lung and Blood Institute: Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation. 2005, 112 (17): 2735-52. 10.1161/CIRCULATIONAHA.105.169404.CrossRefPubMed
21.
go back to reference Alberti KG, Zimmet PZ, Shaw J: The Metabolic Syndrome – A new worldwide definition. Lancet. 2005, 366: 1059-62. 10.1016/S0140-6736(05)67402-8.CrossRefPubMed Alberti KG, Zimmet PZ, Shaw J: The Metabolic Syndrome – A new worldwide definition. Lancet. 2005, 366: 1059-62. 10.1016/S0140-6736(05)67402-8.CrossRefPubMed
22.
go back to reference Yoon YS, Lee ES, Park C, Oh SW: The new definition of the metabolic syndrome by the international diabetes federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised national cholesterol education program: The Korean NHANES Study. Int J Obesity. 2007, 31: 528-34. 10.1038/sj.ijo.0803442.CrossRef Yoon YS, Lee ES, Park C, Oh SW: The new definition of the metabolic syndrome by the international diabetes federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised national cholesterol education program: The Korean NHANES Study. Int J Obesity. 2007, 31: 528-34. 10.1038/sj.ijo.0803442.CrossRef
24.
go back to reference Management & Information Systems Division: Statistical abstracts. Victoria, Seychelles. 2004 Management & Information Systems Division: Statistical abstracts. Victoria, Seychelles. 2004
25.
go back to reference Bovet P, Shamlaye C, Kitua A, Riesen WF, Paccaud F, Darioli R: High prevalence of cardiovascular risk factors in the Seychelles (Indian Ocean). Arterioscler Thromb. 1991, 11 (6): 1730-36.CrossRefPubMed Bovet P, Shamlaye C, Kitua A, Riesen WF, Paccaud F, Darioli R: High prevalence of cardiovascular risk factors in the Seychelles (Indian Ocean). Arterioscler Thromb. 1991, 11 (6): 1730-36.CrossRefPubMed
26.
go back to reference Bovet P, Shamlaye C, Gabriel A, Riesen W, Paccaud F: Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy. BMC Public Health. 2006, 19 (6): 9-10.1186/1471-2458-6-9.CrossRef Bovet P, Shamlaye C, Gabriel A, Riesen W, Paccaud F: Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy. BMC Public Health. 2006, 19 (6): 9-10.1186/1471-2458-6-9.CrossRef
27.
go back to reference Faeh D, William J, Tappy L, Ravussin E, Bovet P: Prevalence, awareness and control of diabetes in the Seychelles and relationship with excess body weight. BMC Public Health. 2007, 7: 163-10.1186/1471-2458-7-163.PubMedCentralCrossRefPubMed Faeh D, William J, Tappy L, Ravussin E, Bovet P: Prevalence, awareness and control of diabetes in the Seychelles and relationship with excess body weight. BMC Public Health. 2007, 7: 163-10.1186/1471-2458-7-163.PubMedCentralCrossRefPubMed
28.
go back to reference Pruijm MT, Madeleine G, Riesen WF, Burnier M, Bovet P: Prevalence of microalbuminuria in the general population of Seychelles and strong association with diabetes and hypertension independent of renal markers. J Hypertens. 2008, 26 (5): 871-77. 10.1097/HJH.0b013e3282f624d9.CrossRefPubMed Pruijm MT, Madeleine G, Riesen WF, Burnier M, Bovet P: Prevalence of microalbuminuria in the general population of Seychelles and strong association with diabetes and hypertension independent of renal markers. J Hypertens. 2008, 26 (5): 871-77. 10.1097/HJH.0b013e3282f624d9.CrossRefPubMed
29.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and B cell function from plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-19. 10.1007/BF00280883.CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and B cell function from plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-19. 10.1007/BF00280883.CrossRefPubMed
30.
go back to reference Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000, 23 (1): 57-63. 10.2337/diacare.23.1.57.CrossRefPubMed Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000, 23 (1): 57-63. 10.2337/diacare.23.1.57.CrossRefPubMed
31.
go back to reference Ikeda Y, Suehiro T, Nakamura T, Kumon Y, Hashimoto K: Clinical significance of the insulin resistance index as assessed by homeostasis model assessment. Endocr J. 2001, 48: 81-86. 10.1507/endocrj.48.81.CrossRefPubMed Ikeda Y, Suehiro T, Nakamura T, Kumon Y, Hashimoto K: Clinical significance of the insulin resistance index as assessed by homeostasis model assessment. Endocr J. 2001, 48: 81-86. 10.1507/endocrj.48.81.CrossRefPubMed
32.
go back to reference Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M: Age standardization of rates: A new WHO standard. Global Program on Evidence for Health Policy; Paper Series No 31. 2005, World Health Organization, Geneva Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M: Age standardization of rates: A new WHO standard. Global Program on Evidence for Health Policy; Paper Series No 31. 2005, World Health Organization, Geneva
33.
go back to reference Balkau B, Charles MA: Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999, 16: 442-43. 10.1046/j.1464-5491.1999.00059.x.CrossRefPubMed Balkau B, Charles MA: Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999, 16: 442-43. 10.1046/j.1464-5491.1999.00059.x.CrossRefPubMed
34.
go back to reference Bochud M, Nussberger J, Bovet P, Maillard MR, Elston RC, Paccaud F, Shamlaye C, Burnier M: Plasma aldosterone is independently associated with the metabolic syndrome. Hypertension. 2006, 48 (2): 239-45. 10.1161/01.HYP.0000231338.41548.fc.CrossRefPubMed Bochud M, Nussberger J, Bovet P, Maillard MR, Elston RC, Paccaud F, Shamlaye C, Burnier M: Plasma aldosterone is independently associated with the metabolic syndrome. Hypertension. 2006, 48 (2): 239-45. 10.1161/01.HYP.0000231338.41548.fc.CrossRefPubMed
35.
go back to reference Cameron AJ, Shaw JE, Zimmet PZ: The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am. 2004, 33 (2): 351-75. 10.1016/j.ecl.2004.03.005.CrossRefPubMed Cameron AJ, Shaw JE, Zimmet PZ: The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am. 2004, 33 (2): 351-75. 10.1016/j.ecl.2004.03.005.CrossRefPubMed
36.
go back to reference Benetos A, Thomas F, Pannier B, Bean K, Jégo B, Guize L: All-Cause and Cardiovascular Mortality Using the Different Definitions of Metabolic Syndrome. Am J Cardiol. 2008, 102 (2): 188-91. 10.1016/j.amjcard.2008.03.037.CrossRefPubMed Benetos A, Thomas F, Pannier B, Bean K, Jégo B, Guize L: All-Cause and Cardiovascular Mortality Using the Different Definitions of Metabolic Syndrome. Am J Cardiol. 2008, 102 (2): 188-91. 10.1016/j.amjcard.2008.03.037.CrossRefPubMed
37.
go back to reference Nilsson PM, Engstrom G, Hedblad B: The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects-a population based study comparing three different definitions. Diabet Med. 2007, 24 (5): 464-72. 10.1111/j.1464-5491.2007.02142.x.CrossRefPubMed Nilsson PM, Engstrom G, Hedblad B: The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects-a population based study comparing three different definitions. Diabet Med. 2007, 24 (5): 464-72. 10.1111/j.1464-5491.2007.02142.x.CrossRefPubMed
38.
go back to reference Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, Morris R, Zavaroni I, van Dam R, Feskins E, Gabriel R, Diet M, Nilsson P, Hedblad B, European Group For The Study Of Insulin Resistance (EGIR): Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab. 2002, 28 (5): 364-76.PubMed Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, Morris R, Zavaroni I, van Dam R, Feskins E, Gabriel R, Diet M, Nilsson P, Hedblad B, European Group For The Study Of Insulin Resistance (EGIR): Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab. 2002, 28 (5): 364-76.PubMed
39.
go back to reference Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K: Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 2004, 164: 1066-76. 10.1001/archinte.164.10.1066.CrossRefPubMed Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K: Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 2004, 164: 1066-76. 10.1001/archinte.164.10.1066.CrossRefPubMed
Metadata
Title
Metabolic syndrome according to different definitions in a rapidly developing country of the African region
Authors
Clara Kelliny
Julita William
Walter Riesen
Fred Paccaud
Pascal Bovet
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2008
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-7-27

Other articles of this Issue 1/2008

Cardiovascular Diabetology 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.